Nom du produit:N-(3-chloroquinoxalin-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide

IUPAC Name:N-(3-chloroquinoxalin-2-yl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide

CAS:522628-94-0
Formule moléculaire:C16H12ClN3O4S
Pureté:95%+
Numéro de catalogue:CM1050312
Poids moléculaire:377.8

Unité d'emballage Stock disponible Prix($) Quantité
CM1050312-1g in stock ŢNJȀ
CM1050312-5g in stock ĽȎƄȎ
CM1050312-10g in stock ĽǯƄȀ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:522628-94-0
Formule moléculaire:C16H12ClN3O4S
Point de fusion:-
Code SMILES:ClC1=C(NS(=O)(=O)C2=CC=C3OCCOC3=C2)N=C2C=CC=CC2=N1
Densité:
Numéro de catalogue:CM1050312
Poids moléculaire:377.8
Point d'ébullition:555.6±60.0 °C at 760 mmHg
N° Mdl:
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.